169 related articles for article (PubMed ID: 30037816)
1. KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study.
Scelo G; Muller DC; Riboli E; Johansson M; Cross AJ; Vineis P; Tsilidis KK; Brennan P; Boeing H; Peeters PHM; Vermeulen RCH; Overvad K; Bueno-de-Mesquita HB; Severi G; Perduca V; Kvaskoff M; Trichopoulou A; La Vecchia C; Karakatsani A; Palli D; Sieri S; Panico S; Weiderpass E; Sandanger TM; Nøst TH; Agudo A; Quirós JR; Rodríguez-Barranco M; Chirlaque MD; Key TJ; Khanna P; Bonventre JV; Sabbisetti VS; Bhatt RS
Clin Cancer Res; 2018 Nov; 24(22):5594-5601. PubMed ID: 30037816
[No Abstract] [Full Text] [Related]
2. Diagnostic role of kidney injury molecule-1 in renal cell carcinoma.
Zhang KJ; Wilson GD; Kara S; Majeske A; Zhang PL; Hafron JM
Int Urol Nephrol; 2019 Nov; 51(11):1893-1902. PubMed ID: 31385177
[TBL] [Abstract][Full Text] [Related]
3. Kidney Injury Molecule-1 (KIM-1) in Blood Plasma of Patients with Clear-Cell Carcinoma.
Kushlinskii NE; Gershtein ES; Naberezhnov DS; Taipov MA; Bezhanova SD; Pushkar' DY; Matveev VB; Stilidi IS
Bull Exp Biol Med; 2019 Jul; 167(3):388-392. PubMed ID: 31346876
[TBL] [Abstract][Full Text] [Related]
4. Circulating biomarkers of one-carbon metabolism in relation to renal cell carcinoma incidence and survival.
Johansson M; Fanidi A; Muller DC; Bassett JK; Midttun Ø; Vollset SE; Travis RC; Palli D; Mattiello A; Sieri S; Trichopoulou A; Lagiou P; Trichopoulos D; Ljungberg B; Hallmans G; Weiderpass E; Skeie G; González CA; Dorronsoro M; Peeters PH; Bueno-de-Mesquita HB; Ros MM; Boutron Ruault MC; Fagherazzi G; Clavel F; Sánchez MJ; Gurrea AB; Navarro C; Quiros JR; Overvad K; Tjønneland A; Aleksandrova K; Vineis P; Gunter MJ; Kaaks R; Giles G; Relton C; Riboli E; Boeing H; Ueland PM; Severi G; Brennan P
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376861
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D binding protein and risk of renal cell carcinoma in the prostate, lung, colorectal and ovarian cancer screening trial.
Kratzer TB; Weinstein SJ; Albanes D; Mondul AM
Int J Cancer; 2020 Aug; 147(3):669-674. PubMed ID: 31659740
[TBL] [Abstract][Full Text] [Related]
6. Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma.
Ramankulov A; Lein M; Kristiansen G; Meyer HA; Loening SA; Jung K
J Cancer Res Clin Oncol; 2007 Sep; 133(9):643-52. PubMed ID: 17479289
[TBL] [Abstract][Full Text] [Related]
7. Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma.
Lee JC; Yotis DM; Lee JY; Sarabusky MA; Shrum B; Champagne A; Ismail OZ; Tutunea-Fatan E; Leong HS; Gunaratnam L
Sci Rep; 2021 Jun; 11(1):11840. PubMed ID: 34088927
[TBL] [Abstract][Full Text] [Related]
8. Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinoma.
Kinouchi T; Uemura M; Wang C; Ishizuya Y; Yamamoto Y; Hayashi T; Matsuzaki K; Nakata W; Yoshida T; Jingushi K; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Ueda Y; Kitae K; Tsujikawa K; Nonomura N
Cancer Sci; 2017 Dec; 108(12):2495-2502. PubMed ID: 28985012
[TBL] [Abstract][Full Text] [Related]
9. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
10. Detection Performance of Circulating MicroRNA-210 for Renal Cell Carcinoma: a Meta-Analysis.
Chen Y; Wang X; Zhu X; Shao S
Clin Lab; 2018 Apr; 64(4):569-576. PubMed ID: 29739083
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of one-carbon metabolism biomarkers and risk of renal cell carcinoma.
Gibson TM; Weinstein SJ; Mayne ST; Pfeiffer RM; Selhub J; Taylor PR; Virtamo J; Albanes D; Stolzenberg-Solomon R
Cancer Causes Control; 2010 Jul; 21(7):1061-9. PubMed ID: 20383577
[TBL] [Abstract][Full Text] [Related]
12. Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis.
Perumal K; Huin WK; Yap NY; Ong TA; Gobe GC; Rajandram R
Med Hypotheses; 2019 Aug; 129():109239. PubMed ID: 31371068
[TBL] [Abstract][Full Text] [Related]
13. Circulating Th22 cells, as well as Th17 cells, are elevated in patients with renal cell carcinoma.
Peng Z; Hu Y; Ren J; Yu N; Li Z; Xu Z
Int J Med Sci; 2021; 18(1):99-108. PubMed ID: 33390778
[TBL] [Abstract][Full Text] [Related]
14. Reduced cytosolic carboxypeptidase 6 (CCP6) level leads to accumulation of serum polyglutamylated DNAJC7 protein: A potential biomarker for renal cell carcinoma early detection.
Li C; Wang J; Hao J; Dong B; Li Y; Zhu X; Ding J; Ren S; Zhao H; Wu S; Tian Y; Wang GQ
Oncotarget; 2016 Apr; 7(16):22385-96. PubMed ID: 26993597
[TBL] [Abstract][Full Text] [Related]
15. Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers.
Liao LM; Weinstein SJ; Pollak M; Li Z; Virtamo J; Albanes D; Chow WH; Purdue MP
Carcinogenesis; 2013 Jan; 34(1):109-12. PubMed ID: 23042303
[TBL] [Abstract][Full Text] [Related]
16. Urinary NGAL and KIM-1: potential association with histopathologic features in patients with renal cell carcinoma.
Shalabi A; Abassi Z; Awad H; Halachmi S; Moskovitz B; Kluger Y; Nativ O
World J Urol; 2013 Dec; 31(6):1541-5. PubMed ID: 23430218
[TBL] [Abstract][Full Text] [Related]
17. Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.
Coca SG; Nadkarni GN; Huang Y; Moledina DG; Rao V; Zhang J; Ferket B; Crowley ST; Fried LF; Parikh CR
J Am Soc Nephrol; 2017 Sep; 28(9):2786-2793. PubMed ID: 28476763
[TBL] [Abstract][Full Text] [Related]
18. Plasma KIM-1 Is Associated with Recurrence Risk after Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805).
Xu W; Puligandla M; Halbert B; Haas NB; Flaherty KT; Uzzo RG; Dutcher JP; DiPaola RS; Sabbisetti V; Bhatt RS
Clin Cancer Res; 2021 Jun; 27(12):3397-3403. PubMed ID: 33832947
[TBL] [Abstract][Full Text] [Related]
19. Serum level of ANGPTL4 as a potential biomarker in renal cell carcinoma.
Dong D; Jia L; Zhou Y; Ren L; Li J; Zhang J
Urol Oncol; 2017 May; 35(5):279-285. PubMed ID: 28110976
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma.
Morrissey JJ; London AN; Lambert MC; Kharasch ED
Am J Nephrol; 2011; 34(5):391-8. PubMed ID: 21912102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
